ACP Journal Club. Review: cholinesterase inhibitors do not reduce progression to dementia from mild cognitive impairment.

@article{Masoodi2013ACPJC,
  title={ACP Journal Club. Review: cholinesterase inhibitors do not reduce progression to dementia from mild cognitive impairment.},
  author={Nasseer Masoodi},
  journal={Annals of internal medicine},
  year={2013},
  volume={158 4},
  pages={
          JC3
        }
}
Review scope Included studies compared ChEIs (donepezil, rivastigmine, galantamine, or tacrine) with placebo for ≥ 1 month in adults with mild cognitive impairment (as defined by each study but including subjective memory complaint and relatively preserved daily functioning). Primary outcomes were progression to dementia, which included Alzheimer disease (National Institute of Neurological and Communicative Disorders and Stroke and Alzheimer’s Disease and Related Disorders Association criteria… CONTINUE READING
7
Twitter Mentions